Sermorelin and ipamorelin are the two peptides people most often compare when they look into raising growth hormone naturally. Both prompt the pituitary gland to release more of your own growth hormone rather than replacing it, but they do it through different signals, they have different histories, and they suit slightly different goals.
Here is how each one works, how they compare on evidence and side effects, why they are often combined, and how a physician decides which fits you.
The short answer
Sermorelin copies the body's growth hormone releasing hormone. Ipamorelin copies ghrelin, a different signal that also triggers growth hormone release. Sermorelin is the more established of the two and was once an FDA approved drug. Ipamorelin is more selective and produces a sharper pulse, but it was never approved and has less human data behind it. Because they work on different receptors, many physicians use them together rather than choosing one.
How sermorelin works
Sermorelin is a lab made version of the first 29 amino acids of growth hormone releasing hormone (GHRH), the signal your hypothalamus uses to tell the pituitary to release growth hormone. It binds the same receptor, so it encourages the pituitary to release growth hormone in its normal pulses, and the body's own brakes, mainly somatostatin, still apply. That built in feedback is a large part of why it is considered a gentler approach than taking growth hormone itself.
Sermorelin was FDA approved in the 1990s under the brand name Geref for children with growth hormone deficiency. The manufacturer stopped making it in 2008 for commercial reasons rather than safety ones. Today it is prescribed as a compounded medication, usually as a small injection under the skin before bed, when the body's largest natural growth hormone pulse happens. We cover what people typically notice, and when, in sermorelin before and after.
How ipamorelin works
Ipamorelin is a five amino acid peptide that mimics ghrelin and acts on the growth hormone secretagogue receptor, a separate pathway from sermorelin. It belongs to a family of growth hormone releasing peptides, and what sets it apart is selectivity. Older peptides in this group raised cortisol and prolactin and could sharply increase appetite, while ipamorelin has much less effect on those hormones in published studies.
Ipamorelin was studied in human trials for recovery of gut function after surgery, but it was never approved for any use. Most of what is known about its growth hormone effects comes from animal research and small human studies. It is also prescribed as a compounded injection, and its status as a compounding ingredient has been under FDA review.
Side by side
- Signal it copies. Sermorelin copies GHRH. Ipamorelin copies ghrelin.
- Effect. Sermorelin supports natural pulses with the body's feedback intact. Ipamorelin produces a sharper, more selective pulse.
- Track record. Sermorelin was an approved drug with decades of clinical use. Ipamorelin was never approved and has thinner human data.
- Dosing. Both are usually small daily injections under the skin, most often at night.
- Common use. Sermorelin for sleep, recovery and gradual body composition change. Ipamorelin for recovery and lean muscle goals, often alongside a GHRH peptide.
There are no head to head trials comparing the two, so claims that one is clearly stronger or better are getting ahead of the evidence.
Why they are often combined
Because sermorelin and ipamorelin act on two different receptors, using them together can produce a larger growth hormone pulse than either one alone, while still relying on your own pituitary. That is the logic behind the blend many clinics offer, and behind the related pairing of CJC-1295 with ipamorelin. We explain the blend in sermorelin and ipamorelin together and the longer acting option in CJC-1295 and ipamorelin.
Side effects and who should avoid them
Most side effects are mild and local. Redness, itching or a small bump at the injection site are the most common. Some people notice flushing, headache or dizziness soon after a dose. Ipamorelin can add mild water retention and a modest increase in hunger. These usually settle, but tell your provider if they persist.
Because both peptides raise growth hormone and IGF-1, they are generally not used in these situations:
- Active cancer or a recent history of cancer. Growth hormone and IGF-1 can influence tissue growth.
- Pregnancy or breastfeeding. There is no safety data.
- Poorly controlled diabetes. Growth hormone can affect blood sugar, so levels need watching.
- Tested athletes. Both are prohibited by the World Anti-Doping Agency.
Sourcing is the other risk. Both peptides are widely sold online as research use only, which means they are not made or checked for human injection. We explain how to check a source in where your peptides actually come from, and our broader view is in are peptides safe.
How Recovery Project decides
At RECOVERY PROJECT, neither peptide is prescribed without a physician-led evaluation of your health history, symptoms, goals and lab work, including IGF-1. Our peptide program operates under Dr. Christian Erikson, MD, our Medical Director. Sermorelin is often the starting point for sleep, recovery and gradual change, ipamorelin is added or chosen when the goals call for it, and some patients do best on a combination. Each prescription is filled as a medical grade compounded medication from a licensed pharmacy and followed up with repeat labs.
More on each program at sermorelin at Recovery Project and ipamorelin at Recovery Project. Women considering sermorelin may also find sermorelin for women useful. Peptide visits are available in person at our Magnolia clinic or by telehealth anywhere in Texas.
Frequently asked questions
They work through different receptors, so strength is hard to compare directly, and there are no head to head human trials. Ipamorelin tends to produce a sharper growth hormone pulse per dose, while sermorelin works more like the body's own signal. Many physicians combine them rather than choosing one.
Neither is better for everyone. Sermorelin is the more established option and is easier to adjust. CJC-1295 with ipamorelin pairs a longer acting releasing hormone with a ghrelin mimetic for a larger combined effect. Your physician chooses based on your goals, labs and how you respond.
Common complaints are injection site redness, headache, flushing, mild water retention and sometimes more hunger. It was never FDA approved and its status for compounding has been under FDA review, so sourcing matters. Like any growth hormone secretagogue, it is not used with active cancer.
Many people notice better sleep and recovery within the first few weeks, but changes in body composition usually take three to six months. Three months is a reasonable first course, after which your physician reviews symptoms and IGF-1 levels to decide whether to continue.
Some people see modest changes in body composition, including less fat around the middle, as growth hormone and IGF-1 rise. Sermorelin is not a weight loss drug, and results depend heavily on sleep, training and nutrition. A medical weight program is a better fit if fat loss is the main goal.
Injections are the standard form. Sermorelin is a peptide that is largely broken down in the digestive tract, and there is little good evidence that oral or under the tongue versions raise growth hormone reliably. A short subcutaneous injection before bed is how it is usually prescribed.
Yes, and it is a common approach. Because they act on two different receptors, the combination can produce a larger natural growth hormone pulse than either alone. We cover the blend in detail in our sermorelin and ipamorelin article.
Ready to feel better?
Book a consultation and build a recovery plan around your goals.
Book a Consultation